The Silent Killer — Chronic Hepatitis B Threatens the Health of Asian Americans and Pacific Islanders.
Chronic hepatitis B can lay dormant for years until the infection has caused life-threatening damage to the liver. We hear the stories of patients living with the disease, and about how a lack of resources and infection patterns put Asian Americans and Pacific Islanders at greater risk. Researchers are working on a cure as activists and medical professionals in the San Francisco Bay Area create a unique model of care for the disease that is being copied around the U.S.
Civic · Mel Baker, Zhe Wu
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
About the ‘Silent Killer’ Series
The San Francisco Public Press examined recent efforts to step up diagnosis, vaccination and treatment for hepatitis B. Chronic hepatitis B affects an estimated 305,000 people in California, with the vast majority of cases affecting people in Asian American and Pacific Islander communities. Deep racial and cultural disparities in illness caused by the hepatitis B virus have persisted for decades. A cure is in trials, but those inequities, along with federal funding cuts, could hamper its rollout.
This reporting was supported with a California Health Equity Fellowship from the USC Annenberg Center for Health Journalism and a grant from the Pulitzer Center.
PART 1: Poorly Tracked Virus Is a ‘Silent Killer’ Affecting Asian Americans Most
PART 2: Stigma, Insufficient Screening Keep Hepatitis B in the Shadows
PART 3: Researchers Seek Hepatitis B Cure as Trump Slashes Health Agency Funding
------------